We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Interchangeability Guideline Could Come Early Next Year, Expert Says
FDA’s Interchangeability Guideline Could Come Early Next Year, Expert Says
The FDA could issue guidance on demonstrating interchangeability between a biosimilar and its reference product by the end of the first quarter of next year.